CRCHD

基本信息

批准号：
8765069
负责人：
GEORGE WILDING
金额：
$ 12.24万
依托单位：
UNIVERSITY OF WISCONSIN-MADISON
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-04-12 至 2018-03-31
项目状态：
已结题

项目摘要

DESCRIPTION (provided by applicant): The University of Wisconsin Carbone Cancer Center (UWCCC) is comprised of 216 research members from 45 departments and 11 schools of the University of Wisconsin Madison. UW-Madison has a long and rich history as an international leader in basic, translational and clinical cancer research reflected in its history of two NCI-designated and -funded cancer research centers founded by Dr. Harold Rusch on the UW-Madison campus. The McArdle Laboratory for Cancer Research was founded in 1940 and received its initial NCI funding in 1946. UWCCC has received continuous NCI funding since 1973 when it was awarded NCI funding as one of the first six comprehensive cancer centers. After a coordinated process during the late 1990's, both centers were consolidated under UWCCC in 2001 when the first NCI Cancer Center Support Grant representing the consolidated centers was awarded. The consolidation of the two centers has generated tremendous enthusiasm and growth for cancer research on the UW-Madison campus over the past ten years. This has resulted in a Center greater than the sum of the two parts existing before the consolidation. With the completion of the Wisconsin Institutes of Medical Research (WIMR) Tower 1 in 2008 and with Tower 2 completion projected for 2013, UWCCC will have approximately 350,000 sq ft of contiguous space dedicated to cancer clinical care and research, a nearly three-fold increase over the past ten years. In addition, the new Wisconsin Institutes of Discovery (WID), a $200 million UW-Madison central campus research facility that also includes the privately-operated Morgridge Institute for Research (MIR), opened in 2011. WID/MIR will house 10 focused research teams of four or more faculty each. Five of these teams are led by UWCCC members representing a strong cancer research presence in the WID/MIR. Three quarters of the faculty in WID will be new recruits to UW-Madison. The three future highest goals of UWCCC are unchanged from the current goals: 1) to conduct the highest quality research into the origins and control of cancer; 2) to translate these research findings to evaluation in the clinic through well-designed clinical trials with corresponding biologic endpoint whenever possible; and 3) to provide the best care possible to all cancer patients by carefully integrating high quality, cutting-edge care with clinical research in a compassionate and individualized manner. UWCCC has $30.7 million in NCI funding (direct) and a total of $83.7 million cancer focused research funding.

描述（由申请人提供）：威斯康星大学碳纤维癌中心（UWCCC）由来自45个系和威斯康星大学麦迪逊大学的11所学校的216名研究成员组成。 UW-Madison作为基础，转化和临床癌症研究的国际领导者具有悠久而悠久的历史，这些研究在其两个NCI指定和资助的癌症研究中心的历史上，由Harold Rusch博士在UW-Madison校园内成立。 McArdle癌症研究实验室成立于1940年，并于1946年获得了最初的NCI资金。自1973年以来，UWCCC已获得NCI的持续资金，当时它被授予NCI资金为前六个综合癌症中心之一。在1990年代后期进行了协调的过程之后，两个中心在2001年UWCCC下合并，当时授予了代表合并中心的第一批NCI癌症中心支持拨款。在过去的十年中，这两个中心的合并对UW-Madison校园的癌症研究产生了极大的热情和增长。这导致了一个大于合并之前存在的两个部分的总和。随着2008年威斯康星州医学研究所（WIMR）1塔的完成，并预计将在2013年完成塔楼2，UWCCC将拥有大约350,000平方英尺的连续空间，用于癌症临床护理和研究，在过去的十年中将有近3倍的增长。此外，威斯康星州新的发现研究所（WID）是一家耗资2亿美元的UW-Madison Central Campus研究机构，其中还包括私人经营的摩格里奇研究所（MIR），于2011年开业。WID/MIR将容纳10个专注的研究团队，分别由四个或更多的教师组成。其中五个团队由UWCCC成员领导，代表WID/MIR的癌症研究存在。 WID教师的四分之三将是UW-Madison的新兵。 UWCCC的未来三个最高目标与当前的目标没有变化：1）对癌症的起源和控制进行最高质量的研究； 2）将这些研究结果转化为在诊所中通过精心设计的临床试验进行评估，并尽可能具有相应的生物学终点； 3）通过以富有同情心和个性化的方式将高质量的尖端护理与临床研究仔细整合到所有癌症患者中。 UWCCC拥有3070万美元的NCI资金（直接），总计8370万美元以癌症为中心的研究资金。